Información: Esta es una versión obsoleta del modelo de datos. En la sección izquierda, bajo "Versiones", se encuentra el historial de versiones. Puede acceder a la versión actual a través del siguiente link: here.
Información:
Error:
ID
21989
Descripción
A Study of the Pharmacokinetics and Immunologic Effects of Lipoic Acid in Multiple Sclerosis; ODM derived from: https://clinicaltrials.gov/show/NCT00676156
Link
https://clinicaltrials.gov/show/NCT00676156
Palabras clave
Versiones (2)
- 13/5/17 13/5/17 -
- 13/5/17 13/5/17 -
Subido en
13 de mayo de 2017
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Eligibility Multiple Sclerosis NCT00676156
Eligibility Multiple Sclerosis NCT00676156
- StudyEvent: Eligibility
Similar models
Eligibility Multiple Sclerosis NCT00676156
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Multiple Sclerosis
Item
definite ms by mcdonald's or poser's criteria
boolean
C0026769 (UMLS CUI [1])
Kurtzke multiple sclerosis rating scale
Item
edss ≤ 7.5
boolean
C0451246 (UMLS CUI [1])
Age
Item
age 18 to 80
boolean
C0001779 (UMLS CUI [1])
Exacerbation of multiple sclerosis
Item
no clinically significant ms exacerbation within 30 days of the screening
boolean
C0581392 (UMLS CUI [1])
CORTICOSTEROIDS FOR SYSTEMIC USE
Item
no systemically administered corticosteroids within 30 days of study entry
boolean
C3653708 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
patient not pregnant or breast feeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
ID.7
Item
no la in previous 2 weeks
boolean
Anticoagulants | Heparin | Coumadin | Aspirin
Item
not on anti-coagulants such as heparin, coumadin, or aspirin during study
boolean
C0003280 (UMLS CUI [1])
C0019134 (UMLS CUI [2])
C0699129 (UMLS CUI [3])
C0004057 (UMLS CUI [4])
C0019134 (UMLS CUI [2])
C0699129 (UMLS CUI [3])
C0004057 (UMLS CUI [4])
Disease At risk Adverse event | Coronary heart disease | Liver diseases | Lung diseases | Diabetes Mellitus
Item
no other significant health problem (e.g. active coronary heart disease, liver disease, pulmonary disease, diabetes mellitus) that might increase risk of patient experiencing adverse events
boolean
C0012634 (UMLS CUI [1,1])
C1444641 (UMLS CUI [1,2])
C0877248 (UMLS CUI [1,3])
C0010068 (UMLS CUI [2])
C0023895 (UMLS CUI [3])
C0024115 (UMLS CUI [4])
C0011849 (UMLS CUI [5])
C1444641 (UMLS CUI [1,2])
C0877248 (UMLS CUI [1,3])
C0010068 (UMLS CUI [2])
C0023895 (UMLS CUI [3])
C0024115 (UMLS CUI [4])
C0011849 (UMLS CUI [5])
Informed Consent Unable
Item
inability to give informed consent
boolean
C0021430 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,2])
Condition Study Subject Participation Status Inappropriate
Item
any condition which would make the patient, in the opinion of the investigator, unsuitable for the study
boolean
C0348080 (UMLS CUI [1,1])
C2348568 (UMLS CUI [1,2])
C1548788 (UMLS CUI [1,3])
C2348568 (UMLS CUI [1,2])
C1548788 (UMLS CUI [1,3])